002950 fundamentals

Key facts

Market capitalization‪5.79 B‬CNY
Founded1992
Employees (FY)‪4.68 K‬
CEO
About

Allmed Medical Products Co., Ltd. engages in the research, development, production and sales of disposable medical consumables. Its products include woven gauze swabs, non-woven swabs, elastic bandage, petrolatum gauze dress, oil emulsion dressing, eye pads, sponges, OR towels, kits, disposable drapes, dry, wet wipes, surgical gown, shoes and boot covers. The company was founded in 1992 and is headquartered in Zhijiang, China.

Ownership
‪‪620.74 M‬‬
Free Float shares
‪‪478.51 M‬‬ (77.09%)
Closely held shares
‪‪142.23 M‬‬ (22.91%)
Free Float shares
‪‪478.51 M‬‬ (77.09%)
Closely held shares
‪‪142.23 M‬‬ (22.91%)
Capital structure
Market cap
‪‪5.79 B‬‬
Debt
‪‪852.06 M‬‬
Minority interest
‪‪24.85 M‬‬
Cash & equivalents
‪‪694.64 M‬‬
Enterprise value
‪‪5.98 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪5.79 B‬‬
Price to earning ratio (P/E)
25.35x
Price to sales ratio (P/S)
1.79x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
25.35x
Price to sales ratio (P/S)
1.79x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪16.00‬
‪32.00‬
‪48.00‬
‪64.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−6%‬
‪0%‬
‪6%‬
‪12%‬
‪18%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−300.00 M‬‬
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Surgery and Wound Care
Infection Protection
Other
Health Care
Advanced Dressing
By country
Period: 2023
Overseas
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
‪‪1.00 B‬‬
Actual
Estimate
Earnings
Next:Apr 26, 2025
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
‪0.00‬
‪0.05‬
‪0.10‬
‪0.15‬
‪0.20‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
7.49%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.30%
Last payment
0.027
Last ex-date
Jun 19, 2024
Dividend history
‪0.25%‬
‪1.35%‬
‪2.45%‬
‪3.55%‬
‪4.65%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−350.00 M‬‬
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬
Assets
Liabilities